Transcription of 透析療法を受ける人の基本 - asahi-net.or.jp
{{id}} {{{paragraph}}}
Example: tourism industry
透析療法を受ける人の基本 - asahi-net.or.jp
140/90mmHg 50 55% 45kg ~ / 2 2013 6% (2% 6% (%) *smoothing method=loess (local polynomial regression fitting)(%)mmHgAverage: % Systolic BP difference(preHD-postHD) ( )( )Hui Zhang: KI 81:1108, 2012 10 B,C A (B) (A) < 500 IL-6 TNF- 2m D PTH - -lightchain >500>15,000 p- OL-HDF Kt/V,nPCR CanaudB,1998) 2m 32 24mg/dL ESHOL 2013 P (LornoyW, 2006 P HD:972 mg HDF:1159mg ESA Hb (Vaslaki, 2006) CONTRAST 2012 Locateli,2010) catch-upgrowth Fishbach,2010 QOL CONTRAST RCT, 2012 RCT,ESHOL,2013 , 30% CONTRAST RCT, 2012 ,Turkish(RCT, 2012) Catch-upgrowth I-HDFvsHD)DMDM PermeatePlugged poresMembraneProtein cake Concentration polarization layer(Boundary layer)Bulk(cross-flow blood)DialysteBackwashGuyton and Hall: Tex
活性型ビタミンD （VitD受容体直接作用，Ca濃度上昇作用） 骨への作用 レニン・アンジオテンシン系抑制 腫瘍細胞の増殖抑制，分化，アポトーシス促進
Loading..
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: